Good for you for keeping a record of your symptoms. Do you also track your functionality? If you are not already doing so, you might want to assign daily ratings to both your symptoms and your functionality. For example, on a scale of 0-10, how tolerable were your symptoms for that day? On a scale of 0-10, how functional were you on that day? Graphing such daily ratings would allow you to see patterns and trends.
In your case, my inclination would be to adopt a conservative approach to a lorazepam to clonazepam crossover. What is the dosage of the lorazepam tablets you are taking? 0.5mg? If so, one possible approach would be to split the tablet in half to get a dose of 0.25mg. Then you could do a two stage crossover as follows:
Stage 1
0.25 clonazepam ODT + 0.125 clonazepam ODT + 0.25mg lorazepam
Hold at the above doses for 10-14 days to give the clonazepam sufficient time to reach steady state. You may experience an uptick in withdrawal symptoms over the first week as the lorazepam is eliminated from your body.
Pay close attention to how you react to the above change to gauge: (1) if the substituted dose of clonazepam is too much, too little, or about right (e.g. some individuals discover that the Ashton equivalent is higher than they need to achieve the desired therapeutic effect) and (2) how you react to the change.
If your symptoms stabilize (i.e. stop changing, become tolerable) after Stage 1, you could proceed to Stage 2.
Stage 2
0.25mg clonazepam ODT + 0.125 clonazepam ODT + 0.125mg clonazepam ODT
Needless to say, you would be wise to discuss all of the above with a pharmacist who understands the pharmacokinetics of benzodiazepines.
That’s excellent news that you have not one but two compounding pharmacies in your town. Do they specialize in compounding or are they ‘regular’ pharmacies that do compounding ‘on the side’? The former is preferable to the latter. If the pharmacies specialize in compounding, a first step you could take is to find out (a) if they are accredited (e.g. PCAB) and (b) what professional associations they belong to (e.g. PCCA). I will also work on a consolidated list of what to look for and questions to ask when vetting a compounding pharmacy.
Your assumption is correct.